Lessons learned from Trypanosoma cruzi test implementation

Transfusion

Volumn 52, Issue 9, 2012, Pages 1849-1851

  Menitove, Jay E ^a   Bennett, Judie Leach ^b   Sher, Graham ^b  

^a Division of New York Blood Center Enterprises   (United States)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; HEALTH CARE COST; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; QUALITY OF LIFE; REVIEW; SEROLOGY; TRYPANOSOMA CRUZI; UNITED STATES;

ANIMALS; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; CHAGAS DISEASE; HEMATOLOGIC TESTS; HUMANS; LEARNING; SEROEPIDEMIOLOGIC STUDIES; TRYPANOSOMA CRUZI;

EID: 84865726234     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03806.x     Document Type: Review

References (11)

1. Schmunis GA,. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Mem Inst Oswaldo Cruz 1999; 94: 93-101.
2. Leiby DA, Herron RM, Read BA, Lenes BA, Stumpf RJ,. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-55.
3. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, Delgado-Mejia M, Pena-Munoz JG,. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006; 46: 298-304.
4. US Department of Health and Human Services. Guidance for industry: use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in whole blood and blood components intended for transfusion. 2010. [cited 2012 Jul 11]. Available from: URL: http://www.fda.gov/ biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/blood/ ucm235855.htm.
5. Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M,. Epidemiological and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 2012; 52: 1901-11.
6. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP,. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012; 52: 1922-30.
7. Benjamin RJ, Stramer SL, Leiby DA, Dodd RY, Fearon M, Castro E,. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012; 52: 1913-21.
8. Kitchen AS, Hewitt PE, Chiodini PL,. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem. Transfusion 2012; 52: 1931-9.
9. Stein J, Besley J, Brook C, Hamill M, Klein E, Krewski D, Murphy F, Richardson M, Sirna J, Skinner M, Steiner R, van Aken P, Devine D,. Risk-based decision-making for blood safety: preliminary report of consensus conference. Vox Sang 2011; 101: 277-81.
10. Leach Bennett J, Blajchman A, Delage G, Fearon M, Devine D,. Proceedings of a consensus conference: risk-based decision making for blood safety. Transfus Med Rev 2011; 25: 267-92.
11. Borkent-Raven B, Janssen MP, van der Poel CL, Bonsel GJ, van Hout BA,. Cost-effectiveness of additional blood screening tests in the Netherlands. Transfusion 2012; 52: 478-88.